You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,962,376


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,962,376
Title:Methods and ophthalmic devices used in the treatment of ocular allergies
Abstract: Ophthalmic devices and methods of treating allergic conjunctivitis are disclosed herein.
Inventor(s): Raja; Ranganath R. (Jacksonville, FL), Mahadevan; Shivkumar (Orange Park, FL), Alti; Azaam (Jacksonville, FL), Molock; Frank F. (Orange Park, FL), Pall; Brain (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc. (Jacksonville, FL)
Application Number:11/686,979
Patent Claim Types:
see list of patent claims
Formulation; Compound; Device;
Patent landscape, scope, and claims:

United States Patent 9,962,376: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,962,376, titled "Methods and ophthalmic devices used in the treatment of ocular allergies," is a significant patent in the field of ophthalmology. This patent, issued to address the treatment of ocular allergies, involves innovative methods and devices. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US9962376B2
  • Authority: United States
  • Prior Art Date: The patent application was filed on November 7, 2006, indicating that the invention was conceived and developed prior to this date[4].

Invention Description

The patent describes methods and ophthalmic devices designed to treat ocular allergies. This includes the use of specific ophthalmic devices, such as contact lenses, and methods for delivering therapeutic agents directly to the eye to alleviate allergic reactions[4].

Scope of the Patent

Technical Field

The patent falls within the technical field of ophthalmology, specifically focusing on the treatment of ocular allergies. This includes the development of ophthalmic devices and methods to deliver therapeutic agents to the eye.

Claims

The patent contains several claims that define the scope of the invention. These claims can be broadly categorized into:

  • Device Claims: These claims describe the ophthalmic devices, such as contact lenses, that are designed to deliver therapeutic agents to the eye.
  • Method Claims: These claims outline the methods for using these devices to treat ocular allergies, including the application and duration of treatment[4].

Claim Analysis

Independent Claims

Independent claims are crucial as they define the broadest scope of the invention. For example, Claim 1 might describe a contact lens with a specific coating or material designed to release a therapeutic agent over a certain period.

Dependent Claims

Dependent claims further narrow down the scope by adding additional features or limitations to the independent claims. For instance, a dependent claim might specify the type of therapeutic agent used or the duration of the treatment.

Patent Landscape

Prior Art

The patent landscape includes prior art that was considered during the examination process. This includes other patents, publications, and known methods for treating ocular allergies. The Common Citation Document (CCD) application, which consolidates prior art cited by multiple patent offices, would be useful in understanding the global prior art landscape[1].

Related Patents

Other patents related to ophthalmic devices and methods for treating ocular allergies are part of the broader patent landscape. For example, European Patent EP-2079439-B1 also deals with similar methods and devices, indicating a global interest in this area of innovation[5].

International Patent Family

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This helps in understanding the global reach and protection of the invention[1].

Economic and Market Impact

Market Demand

The demand for innovative treatments for ocular allergies is significant, given the prevalence of allergic conjunctivitis and other ocular allergies. This patent addresses a specific need in the market, potentially offering a competitive edge to the patent holder.

Competitive Analysis

The competitive landscape includes other companies and researchers working on similar technologies. Analyzing the patent claims and scope helps in understanding how this invention differentiates itself from existing solutions.

Legal and Regulatory Considerations

Patent Enforcement

The enforcement of this patent involves ensuring that other entities do not infringe on the claimed inventions. This includes monitoring for unauthorized use of the ophthalmic devices and methods described in the patent.

Litigation and Disputes

In the event of disputes or litigation, the clarity and specificity of the patent claims are crucial. The consultative group and studies conducted by organizations like ACUS can provide insights into the legal and policy considerations surrounding patent disputes[2].

Future Developments and Trends

Technological Advancements

The field of ophthalmology is continuously evolving, with new technologies and materials being developed. Future developments may include more advanced ophthalmic devices or more effective therapeutic agents.

Regulatory Changes

Changes in regulatory policies or guidelines can impact the patent landscape. For instance, new standards for clinical trials or device approvals could affect how similar patents are granted or enforced in the future.

Key Takeaways

  • Invention Scope: The patent covers specific ophthalmic devices and methods for treating ocular allergies.
  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the invention.
  • Patent Landscape: The patent is part of a broader global landscape of similar inventions and prior art.
  • Market Impact: The patent addresses a significant market need and could offer a competitive edge.
  • Legal Considerations: Clear patent claims and regulatory compliance are essential for enforcement and litigation.

FAQs

What is the main focus of United States Patent 9,962,376?

The main focus of this patent is on methods and ophthalmic devices used in the treatment of ocular allergies.

How can one search for similar patents?

One can use the USPTO's Patent Public Search tool or other international patent databases like the European Patent Office's esp@cenet or the World Intellectual Property Organization's PATENTSCOPE[1].

What is the significance of the Common Citation Document (CCD) in patent searching?

The CCD consolidates prior art cited by multiple patent offices, providing a single point of access to up-to-date citation data for a patent application family[1].

How does the Global Dossier service help in understanding the patent landscape?

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices, along with dossier, classification, and citation data[1].

What are the potential market implications of this patent?

The patent could offer a competitive edge in the market for treating ocular allergies, given the demand for innovative treatments and the specific solutions it provides.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,962,376

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Johnson Johnson Visn ACUVUE THERAVISION WITH KETOTIFEN ketotifen fumarate DRUG-ELUTING CONTACT LENS;OPHTHALMIC 022388-001 Feb 25, 2022 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,962,376

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 059928 ⤷  Subscribe
Australia 2007305205 ⤷  Subscribe
Brazil PI0718374 ⤷  Subscribe
Canada 2664790 ⤷  Subscribe
China 101541303 ⤷  Subscribe
China 104614873 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.